BBA
CBAY
Baker Bros. Advisors’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,170,464
| Closed | -$13.6M | – | 114 |
|
|
2022
Q4 | $13.6M | Hold |
2,170,464
| – | – | 0.08% | 51 |
|
|
2022
Q3 | $7.6M | Hold |
2,170,464
| – | – | 0.05% | 67 |
|
|
2022
Q2 | $6.4M | Hold |
2,170,464
| – | – | 0.04% | 73 |
|
|
2022
Q1 | $6.75M | Hold |
2,170,464
| – | – | 0.04% | 79 |
|
|
2021
Q4 | $7.34M | Hold |
2,170,464
| – | – | 0.04% | 84 |
|
|
2021
Q3 | $7.92M | Hold |
2,170,464
| – | – | 0.03% | 83 |
|
|
2021
Q2 | $9.46M | Hold |
2,170,464
| – | – | 0.04% | 77 |
|
|
2021
Q1 | $9.85M | Sell |
2,170,464
-722,812
| -25% | -$3.28M | 0.04% | 75 |
|
|
2020
Q4 | $16.6M | Sell |
2,893,276
-359,266
| -11% | -$2.06M | 0.06% | 61 |
|
|
2020
Q3 | $23.5M | Buy |
3,252,542
+1,729,750
| +114% | +$12.5M | 0.09% | 49 |
|
|
2020
Q2 | $5.32M | Buy |
+1,522,792
| New | +$5.31M | 0.02% | 79 |
|
|
2019
Q4 | – | Sell |
-5,707,411
| Closed | -$29.2M | – | 106 |
|
|
2019
Q3 | $29.2M | Hold |
5,707,411
| – | – | 0.2% | 36 |
|
|
2019
Q2 | $40.9M | Hold |
5,707,411
| – | – | 0.28% | 33 |
|
|
2019
Q1 | $75.8M | Buy |
5,707,411
+789,711
| +16% | +$10.5M | 0.49% | 20 |
|
|
2018
Q4 | $38.7M | Hold |
4,917,700
| – | – | 0.32% | 27 |
|
|
2018
Q3 | $54.5M | Hold |
4,917,700
| – | – | 0.36% | 25 |
|
|
2018
Q2 | $66M | Buy |
4,917,700
+1,000,000
| +26% | +$13.4M | 0.5% | 22 |
|
|
2018
Q1 | $50.9M | Buy |
3,917,700
+925,925
| +31% | +$12M | 0.43% | 27 |
|
|
2017
Q4 | $27.5M | Hold |
2,991,775
| – | – | 0.24% | 38 |
|
|
2017
Q3 | $24.1M | Buy |
2,991,775
+1,700,000
| +132% | +$13.7M | 0.2% | 34 |
|
|
2017
Q2 | $7.44M | Sell |
1,291,775
-121,724
| -9% | -$701K | 0.07% | 55 |
|
|
2017
Q1 | $6.08M | Buy |
1,413,499
+1,104,231
| +357% | +$4.75M | 0.05% | 61 |
|
|
2016
Q4 | $535K | Buy |
+309,268
| New | +$535K | 0.01% | 119 |
|